Ikena Oncology Inc IKNA.O :
* IKENA ONCOLOGY ANNOUNCES STRATEGIC UPDATE
* IKENA ONCOLOGY INC: IK-595 DOSE ESCALATION CONTINUES IN
RAS AND
RAF MUTANT CANCERS; ENCOURAGING PK AND PD PROFILE SHOWN TO DATE
* IKENA ONCOLOGY INC: IKENA TO DISCONTINUE DEVELOPMENT OF
IK-930
* IKENA ONCOLOGY INC: EXPLORING STRATEGIC OPTIONS TO
MAXIMIZE
SHAREHOLDER VALUE
* IKENA ONCOLOGY INC: EXECUTING A WORKFORCE REDUCTION OF
APPROXIMATELY 53%
* IKENA ONCOLOGY INC: PROJECTING CASH AND EQUIVALENTS AT
DECEMBER
31, 2024 TO RANGE FROM $110 MILLION TO $120 MILLION
Source text for Eikon: ID:nGNX1nmBp5
Further company coverage: IKNA.O